Table 2.
Compared Pairs (n) | rADC (10) | rADC (25) | rADC (75) | rADC (90) | Skewness | Kurtosis | Entropy | rADC (Mean) | rADC (Min) | rADC (Max) |
---|---|---|---|---|---|---|---|---|---|---|
DMG(30)/ midGBM-H3wt (14) |
1.23/1.10 | 1.31/1.23 | 1.64/1.59 | 1.83/1.80 | 1.50/0.85 | 4.54/1.02 | 4.27/4.33 | 1.51/1.43 | 0.86/0.74 | 2.92/2.80 |
p-value | 0.083 | 0.445 | 0.686 | 0.780 | 0.016 | 0.002 | 0.737 | 0.446 | 0.128 | 0.633 |
95%-CI | −0.01–0.26 | −013–0.29 | −0.18–0.26 | −0.21–0.27 | 0.12–1.17 | 1.33–5.69 | 0.46–0.33 | −012–0.28 | −0.03–0.24 | −0.35–0.58 |
DMG-GBMneg(13)/ midGBM-H3wt (14) | 1.33/1.10 | 1.46/1.23 | 1.75/1.59 | 1.94/1.80 | 1.19/0.85 | 4.21/1.02 | 4.39/4.33 | 1.59/1.44 | 1.00/0.74 | 2.66/2.81 |
p-value | 0.012 | 0.027 | 0.210 | 0.298 | 0.420 | 0.083 | 0.838 | 0.182 | <0.001 | 0.589 |
95%-CI | 0.05–0.39 | 0.02–0.42 | −0.09–0.41 | −0.13–0.42 | −0.53–1.20 | −0.47–6.84 | −0.48–0.58 | −0.07–0.38 | 0.14–0.36 | −0.69–0.40 |
DMG-GBMneg(13)/ DMG-GBMpos (17) | 1.33/1.15 | 1.46/1.20 | 1.75/1.55 | 1.94/1.74 | 1.19/1.74 | 4.21/4.79 | 4.39 /4.17 | 1.59/1.46 | 1.00/0.55 | 2.66/3.06 |
p-value | 0.036 | 0.028 | 0.141 | 0.178 | 0.253 | 0.779 | 0.403 | 0.279 | 0.001 | 0.090 |
95%-CI | −0.01–0.37 | −0.00–0.51 | −0.07–0.46 | −0.09–0.49 | −1.53–0.41 | −4.81–3.64 | −0.29–0.72 | −0.11–0.37 | 0.12–0.39 | −0.96–0.073 |
All numbers shown are mean values. rADC: relative ADC value; min: minimum; max: maximum; DMG: diffuse midline glioma, H3 K27M-mutant; midGBM-H3wt: glioblastoma of the midline structures, H3 K27M-wildtype.; DMG-GBMneg: diffuse midline glioma, H3 K27M-mutant without glioblastoma histology; DMG-GBMpos: diffuse midline glioma, H3 K27M-mutant with glioblastoma histology; CI: confidence interval regarding differences of mean values in each compaired pair. Significant values are shown in bold (t-test).